In a $10.5m cash deal, Kelpac Medical, a medical packaging and tubing solutions provider and a subsidiary of PPC Industries, has acquired medical device contract manufacturer, Xeridiem Medical Devices, from Fenner.

The acquisition gives the acquirer access to specialty products offered by Xeridiem, including liquid injection moulding, silicone extrusive and silicone device assembly, which will be offered to its new and existing customers.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Danaher Corporation, a global science and technology innovator, through its wholly-owned subsidiary Copper Merger Sub, has agreed to acquire California-based molecular diagnostics company, Cepheid, for approximately $4bn.

Pursuant to the definitive agreement, Copper Merger Sub will be merged with and into Cepheid, which will become a wholly-owned subsidiary and part of Danaher’s $5bn Diagnostics segment.

"The acquisition will allow Danaher to expand and secure a strong position in molecular diagnostics segment."

The acquisition will allow Danaher to expand and secure a strong position in molecular diagnostics segment.

See Also:

Blockade Medical, a developer of catheter-based therapeutic devices, has been acquired by BALT International, a manufacturer of interventional neuro-radiology devices, for an undisclosed sum.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The acquisition will allow BALT to enter the US market and to expand its presence in important global markets. BALT will also gain access to Blockade’s Barricade coil system, which complements its existing product portfolio.

The partnership will focus on developing and marketing more innovative neurovascular devices that will help treat aneurysms, stroke and other neurovascular conditions.